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Introduction
The four species of the bacterium Shigella (S. sonnei, S. flexneri, S. boydii and S. dysenteriae) cause dysentery and are transmitted via the faecal-oral route. Shigellosis is the second leading cause of diarrhoeal deaths worldwide, and the highest burden is found in lower-to-middle income countries [1] . In high income countries, shigellosis has historically been associated with either travelassociated infections or self-limited transmission in community risk-groups. However, since being identified as a sexually transmitted infection (STI) in 1974 in San Francisco's gay community [2, 3] , sustained sexual transmission has become an important component of Shigella spp. epidemiology.
Outbreaks of S. sonnei and S. flexneri among gay, bisexual and other men who have sex with men (GBMSM) have been reported in urban settings across North America, Europe, Asia and Oceania [4] [5] [6] [7] [8] [9] [10] [11] [12] .
In England, Shigella spp. epidemiology has changed markedly in the past decade; from being a predominantly travel-associated infection, to one where domestically-acquired infections in men account for a large and increasing proportion of diagnoses, with national surveillance data, case questionnaires and outbreak investigations suggesting considerable and sustained sexual transmission within specific sexual networks [4, 13, 14] . Since 2009, overlapping GBMSM-associated epidemics of S. flexneri serotype 3a, followed by S. flexneri serotype 2a, and more recently S. sonnei, have emerged, while case numbers have remained stable in females and travel-associated cases [13] .
Whole genome sequencing (WGS) studies have been used to determine factors driving the emergence and transmission of Shigella spp. and have demonstrated that certain community outbreaks of shigellosis in the UK belonged to prolonged, global epidemics [5, [15] [16] [17] [18] . These analysis have shown that lineages of S. flexneri serotypes 3a and 2a have exhibited intercontinental spread via sexual transmission in GBMSM networks, and subsequently acquired multiple antimicrobial resistance (AMR) determinants [5, 17] . Within the S. sonnei population, Baker et al. (2018) [16] defined four clades associated with transmission in GBMSM communities, all within lineage III the dominant extant lineage both in the UK and globally [19, 20] . A two-year population-level study of all cultured Shigella isolates in the state of Victoria, Australia (2016-2018) identified 2 predominant MSM lineages circulating [21] ; the S. flexneri 2a lineage described above and an MDR S. sonnei clade associated with reduced susceptibility to azithromycin, trimethoprim-sulfamethoxazole and ciprofloxacin.
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The implementation of WGS in 2015 at Public Health England (PHE) has enhanced surveillance and facilitated the monitoring of transmission of Shigella spp.in England [20, 22] . This article uses national surveillance data from 2015 to 2018 to describe the epidemiology of Shigella spp. in England in the post-WGS era. We undertook epidemiological and phylogenetic analyses of Shigella isolates referred to the GBRU to explore recent characteristics and patterns of transmission of shigellosis in England to better inform the public health response. We examined trends in travelassociated and non-travel associated acquisition by gender to assess evidence for ongoing sexual transmission of Shigella spp. among men and report on genomic subtype and antimicrobial resistance changes across the population.
Methods

Data collection
The 
Data analysis
Microbiological typing data from all isolates of Shigella spp. submitted to GBRU between 2015 and 2018 were extracted and analysed. Travel-associated cases were defined as those reporting recent foreign travel to any country (including both endemic high-risk countries and low-risk countries) seven days prior to the onset of symptoms, based on information from laboratory reports. Travel history is captured for between 60-70% of cases of Shigella spp.; and therefore, if no travel history is reported it cannot be inferred that the case did not travel. Laboratory surveillance data lacks patient sexual orientation. However, in line with previous work, we calculated gender ratios as an indicator of cases that may be attributed to sexual transmission among GBMSM [13, Mitchell et al. Microbial Genomics (accepted)].
Whole genome sequencing
Since 2015, microbiological typing has been performed at PHE using WGS [20, 22] . DNA was extracted for sequencing on the Illumina HiSeq 2500 instrument. Quality and adapter trimmed Illumina reads aligned to the S. sonnei reference genome Ss46 (Genbank accession: NC_007384.1) or the S. flexneri serotype 2a strain 2457T (AE014073.1) using BWA MEM v0.7.12 [23] . Single Nucleotide Polymorphisms (SNPs) were identified using GATK v2.6.5 [24] in unified genotyper mode.
Core genome positions that had a high-quality SNP (>90% consensus, minimum depth 10x, MQ >= 30) in at least one isolate were extracted and RaxML v8.2.8 [25] used to derive the maximum likelihood phylogeny of the isolates after first removing regions of the genome predicted to have undergone horizontal exchange using Gubbins v2.0.0 [26] . Hierarchical single linkage clustering was performed on the pairwise SNP difference between all isolates at various distance thresholds (Δ250, Δ100, Δ50, Δ25, Δ10, Δ5, Δ0) [27] . Genome-derived serotyping and AMR-conferring genes and SNPs was performed using the GeneFinder tool (https://github.com/phe-bioinformatics/gene_finder) [21, 28] . Resistance to streptomycin, tetracycline, the sulphonamides and trimethoprim in Shigella species is high, and trends have been consistent for many years [5, [15] [16] [17] 28] . We therefore focused our AMR analysis on the presence of genomic makers of resistance to macrolides (specifically ermB and mphA) and fluroquinolones (specifically mutations in the quinolones resistance determining regions (QRDR) of gyrA and parC), as the trends in resistance to these clinically relevant classes of antimicrobials fluctuated during the study period (data not shown).
FASTQ reads from all sequences in this study can be found at the PHE Bioproject PRJNA315192. For international context, 110 S. sonnei sequences isolated from Australian MSMs, previously reported by Ingle et al. (2019) , were processed as above for phylogenetic comparison.
Results
First, we analysed the demographic data available, specifically age, sex and travel history linked to the reference laboratory confirmed cases of shigellosis in England for all Shigella species and then for each individual species of Shigella. We then analysed the WGS data for genomic markers of resistance to azithromycin (ermB and mphA) and ciprofloxacin (mutations in the QRDR of gyrA and parC) for all Shigella species and for each individual species of Shigella. Finally, we investigated the trends in the number of cases and resistance to azithromycin and ciprofloxacin, among S. flexneri 2a and S. flexneri 3a and the clades of S. sonnei previously associated with sexual transmission in men. During the study period, the number of isolates of Shigella spp. referred from non-travel associated adult male cases exceeded cases reporting recent travel at every time point, although marked fluctuations were observed ( Figure 1 ). An increase of adult, male, non-travel-associated cases was first observed in 2013, as previously reported by Simms et al. 2015 and attributed to MSM transmission [13] (Figure 1 ). During the time-frame of this study, adult, male, non-travel cases of shigellosis remained at epidemic levels throughout the first quarter of 2015 before falling by 46% from 2015 to 2016 (674 to 364 cases), but subsequently re-emerged from 2017 onwards.
Epidemiology of shigellosis in England
Speciation, serotyping and analysis of patient demography
Of the 4950 isolates of Shigella submitted to GBRU between 2015 and 2018, the highest proportion were S. sonnei (n = 2695), followed by S. flexneri (n = 1943), S. boydii (n = 201) and S. dysenteriae (n = 111) ( Table 1 ). The most common S. flexneri serotypes were 2a (n=1113/1943, 57.2%), 1b (n=254/1943, 13.1%) and 3a (n=206/1943, 10.6%). The most common serotypes of S. boydii were serotype 1 (n=24/201, 11.9%), serotype 2 (n=42/201, 20.9%), and serotype 4 (n=23/201, 11.4%), and the most common serotype of S. dysenteriae was serotype 2 (n=33/110, 30.0%). All isolates of S. sonnei express the same somatic antigen and therefore cannot be serotyped.
Cases of S. dysenteriae (60.4%) or S. boydii (59.2%) were significantly more associated with recent foreign travel than cases infected with S. sonnei (36.8%) or S. flexneri (28.2%) (p-value <0.001) ( Table   1 ). Across all species, a similar proportion of cases were among adults, the lowest proportion was in cases of S. dysenteriae (77.5%) and the highest in S. flexneri (83.7%). A significantly higher proportion of cases were male for S. sonnei (54.6%) and S. flexneri (69.1%) compared to S. boydii (43.8%) and S. dysenteriae (39.6%) (Chi-Squared p-value <0.001) ( Table 1) .
Genomic surveillance of markers of antimicrobial resistance to azithromycin and ciprofloxacin 7
The genome-derived AMR profiles were available for 4057/4950 (81.4%) isolates of Shigella in the study. Determinants encoding azithromycin resistance, ermB and mphA, were most commonly detected in male, non-travel cases of S. flexneri and S. sonnei, with 45% displaying this resistance genotype compared to <5% non-travel female cases (males reporting travel n=63/660, 9.5%; males, non-travel n=776/1728, 45.0%; females reporting travel n = 5/794, 0.6%; females, non-travel n = 42/875, 4.8%) ( Table 2 ). No azithromycin resistance was detected in S. boydii or S. dysenteriae isolates. Overall resistance to azithromycin remained stable during the study period, although a downward trend was observed in azithromycin resistance associated with S. flexneri isolates from male cases and an upward trend identified in isolates of S. sonnei from male cases ( Figure 2 ).
Triple mutations in the QRDR known to confer resistance to ciprofloxacin were higher in males than females but similar proportions were detected in travel and non-travel cases in both men and woman (males reporting travel n=172/660, 26.1%; males, non-travel n=456/1728, 26.4%; females reporting travel n = 171/794, 21.5%; females, non-travel n = 178/875, 20.3%). Analysis of the available data from adult non-travel cases of S. flexneri and S. sonnei showed that triple QRDR mutations were most commonly identified in isolates of S. sonnei from males ( Table 2) . Throughout the study period the proportion of shigellae with ciprofloxacin-resistance conferring QRDR mutations was stable in females and males reporting travel. However, a proportional increase was identified in the male non-travel associated cases. Stratification of these data by Shigella species showed that this trend was caused by an increase in the number of isolates of S. sonnei (Figure 4 ). By 2018, 80% of adult male non-travel cases had triple QRDR mutations. isolates contained triple mutations in QRDR and carried the pKRS100 plasmid encoding resistance to azithromycin as reported in the English Clade 5 isolates.
Discussion
In this study we present evidence that the previous GBMSM-associated epidemics of S. flexneri Research has shown that proactive campaigns through targeted social media and leaflets in sexual health clinics have failed to raise awareness of shigellosis among GBMSM [29] . Despite this, the number of cases of S. sonnei and S. flexneri 2a diagnoses followed similar trends of decline between August 2015 to August 2017. Whilst S. flexneri 2a and 3a continued to fall, we report an emerging epidemic of S. sonnei among men in England without travel history from August 2017 onwards. S.
sonnei is now the most prevalent endemically-acquired species among this population by orders of magnitude. It is possible that changes to the dominant sub-type reflect levels of herd immunity [30] , and that new sub-types have the potential to enter and spread within the GBMSM population under the right conditions. Continued monitoring of typing data will provide insight into the future trends in sub-type prevalence and potential strain replacement events.
Studies of ultraorthodox Jewish communities in Israel and abroad [31] have shown that in endemic regions the incidence of S. sonnei shigellosis follows a cyclic pattern with epidemics every 2 years.
The timing of these cyclical epidemics of S. sonnei shigellosis are attributed to the waning rate of natural immunity to the organism [30, 31] . It is likely that a similar phenomenon occurs among GBMSM; natural exposure to Shigella spp. through intensive shigellosis epidemics in the GBMSM community may also increase immunity levels in individuals belonging to sexual networks. Herd immunity may be sufficient to temporarily reduce the circulation of Shigella species in these networks and prevent epidemics being sustained in subsequent years. However, eventual waning levels of antibodies could lead to a decrease in the herd immunity below a critical level, and thus enable renewed epidemic transmission of shigellosis in MSM. This phenomenon may also facilitate strain replacement events from strains with different immunogenic properties or fitness profiles.
Given the indication here that we should anticipate repeated epidemics of strains imported from endemic areas, future studies to develop a predictive framework from genomic information would be beneficial.
Given the ever-increasing reports of AMR in Shigella spp. and evidence that strains harbouring mobile resistance-conferring plasmids can spread intercontinentally through sexual transmission [5] , therapy guided according to susceptibility testing should be a priority. Previous studies have discussed the role of AMR in driving transmission of shigellosis in the MSM community, and azithromycin resistance is regarded as a marker for isolates associated with sexual transmission among MSM [5, 17] . During the peak of MSM transmission in 2014, only one of the four Shigella sonnei clades (clades 1-4) associated with MSM transmission was resistant to ciprofloxacin [16] . Of concern in this study is that the majority of suspect MSM-associated cases are now resistant to both azithromycin and ciprofloxacin. The Clade 5 strain causing the majority of cases in 2017-18 emerged from the same travel-associated clade as clade 1. Given this repeated epidemiological occurrence, it is likely that resistance to ciprofloxacin has driven, or at least contributed to, the emergence and dissemination of clade 5.
Current WHO guidelines recommend the use of fluoroquinolones as the first-line treatment for shigellosis. The increasing trend in resistance to fluroquinolones observed in S. sonnei is a public health concern with respect to both the increased likelihood of treatment failures, and to transmission of fluoroquinolone-resistant strains of S. sonnei to the wider community. Evidence of transmission of S. flexneri previously associated with GBMSM transmission spreading to the wider community has been described [32] . Data on epidemiologically-dominant AMR profiles in Shigella spp. would be a beneficial resource to be shared with clinicians to raise awareness and direct appropriate clinical management [33] .
Whilst WGS provides highly-detailed and informative information on genetically-linked clusters [32] , a lack of patient exposure data, including sexual behavioural data, congregational settings, food and travel history linked to isolates within these clusters hinders the accurate determination of the impact of sexual transmission in shigellosis epidemiology and the most appropriate public health intervention. Collecting enhanced surveillance data for cases of shigellosis is warranted in order to help distinguish between MSM and other forms of transmission requiring different public health actions.
Given the diversity of clinical settings in which shigellosis-affected MSM may present, it is important to consider awareness among clinicians. Healthcare professionals should be aware of the importance of sensitively obtaining sexual history and provide advice about the risk of sexual transmission and the need to avoid sexual activity for at least one week after symptoms cease, and how to prevent onward transmission through sexual and non-sexual conatcts. GBMSM with sexually acquired shigellosis are at high risk of STIs and HIV and should be referred to a sexual health clinic for comprehensive HIV and STI testing and partner notification [4] . From a patient perspective, dense sexual networks, diverse sexual practices including chemsex, and STI and/or HIV co-infection may contribute to the ongoing transmission of Shigella spp. among GBMSM [32, 33] . Partner notification and referral for appropriate HIV/STI screening should also be considered. Given the increasing diagnoses of other sexually transmitted infections seen among GBMSM, such as gonorrhoea, syphilis and lymphogranuloma venereum, in the United Kingdom in recent years, [34, 35] , https://www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-datatables] and the threat of AMR, strengthened surveillance of Shigella spp. transmission is warranted. The views expressed are those of the authors and not necessarily those of the NIHR, or PHE.
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